Our insight into antitumour immune responses has increased considerably during the past zzso yet the development of immunotherapy as a treatment modality for cancer has been hampered by several zzso These include difficulties in the selection of the optimal dose and zzso the methods of zzso and financial zzso Although durable clinical zzso have been observed with various zzso zzso the percentage of patients who benefited from these interventions has remained too small to justify the general use of such zzso zzso the recent positive results of clinical trials with novel zzso drugs as well as the unexpected finding of a positive interaction between immunotherapy and chemotherapy may zzso a new era for the immunotherapy of zzso 
